Atlas Trials

Assess the Effect of Metaxalone 640 mg (M640) Compared to Tizanidine 8 mg on Truck Driving Ability and Cognition

Clinical trial NCT06382662 · COMPLETED

Trial details

NCT number
NCT06382662
Sponsor
Primus Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cognitive Impairment
Start date
2024-04-29
Primary completion
2024-12-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.